Consolidation is skyrocketing in gastroenterology, particularly with private equity – nearly 10% of U.S. gastroenterologists are part of PE-backed practices, according to a 2023 study published in Gastroenterology & Hepatology. Here are five major private equity transactions shaping the gastroenterology landscape: 1. One GI and Webster Equity Partners In 2020, Webster Equity Partners launched One […]
The post The game-changing gastroenterology deals and what they mean for the industry appeared first on Becker’s ASC.